PMID- 16160704 OWN - NLM STAT- MEDLINE DCOM- 20060606 LR - 20150311 IS - 0893-133X (Print) IS - 0893-133X (Linking) VI - 31 IP - 5 DP - 2006 May TI - Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol. PG - 1048-55 AB - The use of 3,4-methylenedioxymethamphetamine (MDMA) has frequently been associated with increased levels of impulsivity during abstinence. The effects of MDMA on measures of impulsivity, however, have not yet been studied during intoxication. The present study was designed to assess the acute effects of MDMA and alcohol, alone and in combination, on behavioral measures of impulsivity and risk-taking behavior. A total of 18 recreational users of MDMA entered a double-blind placebo-controlled six-way crossover study. The treatments consisted of MDMA 0, 75, and 100 mg with and without alcohol. Alcohol dosing was designed to achieve a peak blood alcohol concentration (BAC) of about 0.06 g/dl during laboratory testing. Laboratory tests of impulsivity were conducted between 1.5 and 2 h post-MDMA and included a stop-signal task, a go/no-go task, and the Iowa gambling task. MDMA decreased stop reaction time in the stop-signal task indicating increased impulse control. Alcohol increased the proportion of commission errors in the stop-signal task and the go/no-go task. Signal detection analyses of alcohol-induced commission errors indicated that this effect may reflect impairment of perceptual or attentive processing rather than an increase of motor impulsivity per se. Performance in the Iowa gambling task was not affected by MDMA and alcohol, but there was a nonsignificant tendency towards improvement following alcohol intake. None of the behavioral measures of impulsivity showed a MDMA x alcohol interaction effect. The lack of interaction indicated that the CNS stimulant effects of MDMA were never sufficient to overcome alcohol-induced impairment of impulse control or risk-taking behavior. FAU - Ramaekers, Johannes G AU - Ramaekers JG AD - Experimental Psychopharmacology Unit, Department of Neurocognition, Faculty of Psychology, Maastricht University, Maastricht, The Netherlands. j.ramaekers@psychology.unimaas.nl FAU - Kuypers, Kim P C AU - Kuypers KP LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0 (Central Nervous System Depressants) RN - 0 (Hallucinogens) RN - 0 (Placebos) RN - 3K9958V90M (Ethanol) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Acute Disease MH - Adult MH - Alcohol-Induced Disorders, Nervous System/diagnosis/physiopathology MH - Brain/*drug effects/physiopathology MH - Central Nervous System Depressants/adverse effects/antagonists & inhibitors MH - Cross-Over Studies MH - Decision Making/drug effects/physiology MH - Dose-Response Relationship, Drug MH - Double-Blind Method MH - Drug Interactions MH - Ethanol/adverse effects/*antagonists & inhibitors MH - Female MH - Hallucinogens/adverse effects MH - Humans MH - Impulsive Behavior/*chemically induced/diagnosis/physiopathology MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects MH - Neural Inhibition/drug effects/physiology MH - Neuropsychological Tests MH - Placebos MH - Psychomotor Performance/drug effects/physiology MH - Reaction Time/drug effects/physiology EDAT- 2005/09/15 09:00 MHDA- 2006/06/07 09:00 CRDT- 2005/09/15 09:00 PHST- 2005/09/15 09:00 [pubmed] PHST- 2006/06/07 09:00 [medline] PHST- 2005/09/15 09:00 [entrez] AID - 1300894 [pii] AID - 10.1038/sj.npp.1300894 [doi] PST - ppublish SO - Neuropsychopharmacology. 2006 May;31(5):1048-55. doi: 10.1038/sj.npp.1300894.